Header Logo

Chad A Hamilton

TitleResident
InstitutionUniversity of Oklahoma Health Sciences Center
DepartmentPathology
AddressBMSB 451
940 Stanton L Young Blvd
Oklahoma City OK 73104
Phone405/271-2422
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Winkler SS, Tian C, Casablanca Y, Bateman NW, Jokajtys S, Kucera CW, Tarney CM, Chan JK, Richardson MT, Kapp DS, Liao CI, Hamilton CA, Leath CA, Reddy M, Cote ML, O'Connor TD, Jones NL, Rocconi RP, Powell MA, Farley J, Shriver CD, Conrads TP, Phippen NT, Maxwell GL, Darcy KM. Racial, ethnic and country of origin disparities in aggressive endometrial cancer histologic subtypes. Gynecol Oncol. 2024 Jan 25; 184:31-42. PMID: 38277919.
      Citations:    Fields:    
    2. Kucera CW, Tian C, Tarney CM, Presti C, Jokajtys S, Winkler SS, Casablanca Y, Bateman NW, Mhawech-Fauceglia P, Wenzel L, Hamilton CA, Chan JK, Jones NL, Rocconi RP, O'Connor TD, Farley JH, Shriver CD, Conrads TP, Phippen NT, Maxwell GL, Darcy KM. Factors Associated With Survival Disparities Between Non-Hispanic Black and White Patients With Uterine Cancer. JAMA Netw Open. 2023 04 03; 6(4):e238437. PMID: 37067801; PMCID: PMC10111180.
      Citations: 1     Fields:    Translation:Humans
    3. Casablanca Y, Wang G, Lankes HA, Tian C, Bateman NW, Miller CR, Chappell NP, Havrilesky LJ, Wallace AH, Ramirez NC, Miller DS, Oliver J, Mitchell D, Litzi T, Blanton BE, Lowery WJ, Risinger JI, Hamilton CA, Phippen NT, Conrads TP, Mutch D, Moxley K, Lee RB, Backes F, Birrer MJ, Darcy KM, Maxwell GL. Improving Risk Assessment for Metastatic Disease in Endometrioid Endometrial Cancer Patients Using Molecular and Clinical Features: An NRG Oncology/Gynecologic Oncology Group Study. Cancers (Basel). 2022 Aug 23; 14(17). PMID: 36077609; PMCID: PMC9454742.
      Citations: 1     
    4. Nolin AC, Tian C, Hamilton CA, Casablanca Y, Bateman NW, Chan JK, Cote ML, Shriver CD, Powell MA, Phippen NT, Conrads TP, Maxwell GL, Darcy KM. Conditional estimates for uterine serous cancer: Tools for survivorship counseling and planning. Gynecol Oncol. 2022 07; 166(1):90-99. PMID: 35624045.
      Citations:    Fields:    Translation:Humans
    5. Katebi Kashi P, Dengler KL, Hamilton CA. Lipoma or Liposarcoma? Robotic Resection of a Retroperitoneal Mass. J Obstet Gynaecol Can. 2022 10; 44(10):1095-1096.e1. PMID: 34197963.
      Citations:    Fields:    Translation:Humans
    6. Bateman NW, Tarney CM, Abulez T, Soltis AR, Zhou M, Conrads K, Litzi T, Oliver J, Hood B, Driggers P, Viollet C, Dalgard C, Wilkerson M, Catherino W, Hamilton CA, Darcy KM, Casablanca Y, Al-Hendy A, Segars J, Conrads TP, Larry Maxwell G. Proteogenomic landscape of uterine leiomyomas from hereditary leiomyomatosis and renal cell cancer patients. Sci Rep. 2021 04 30; 11(1):9371. PMID: 33931688; PMCID: PMC8087684.
      Citations: 5     Fields:    Translation:Humans
    7. Hamilton CA, Pothuri B, Arend RC, Backes FJ, Gehrig PA, Soliman PT, Thompson JS, Urban RR, Burke WM. Endometrial cancer: A society of gynecologic oncology evidence-based review and recommendations. Gynecol Oncol. 2021 03; 160(3):817-826. PMID: 33516529.
      Citations: 23     Fields:    Translation:Humans
    8. Hamilton CA, Pothuri B, Arend RC, Backes FJ, Gehrig PA, Soliman PT, Thompson JS, Urban RR, Burke WM. Endometrial cancer: A society of gynecologic oncology evidence-based review and recommendations, part II. Gynecol Oncol. 2021 03; 160(3):827-834. PMID: 33451724.
      Citations: 11     Fields:    Translation:Humans
    9. Duska LR, Scalici JM, Temkin SM, Schwarz JK, Crane EK, Moxley KM, Hamilton CA, Wethington SL, Petroni GR, Varhegyi NE, Clift SH, Bullock TNJ, Showalter TN. Results of an early safety analysis of a study of the combination of pembrolizumab and pelvic chemoradiation in locally advanced cervical cancer. Cancer. 2020 11 15; 126(22):4948-4956. PMID: 32910478.
      Citations: 15     Fields:    Translation:Humans
    10. Hamilton CA, Maxwell GL, Casablanca Y. Gynecologic Oncology in the Department of Defense. Semin Reprod Med. 2019 09; 37(5-06):222-226. PMID: 32357376.
      Citations:    Fields:    Translation:Humans
    11. Awad E, Paladugu R, Jones N, Pierce JY, Scalici J, Hamilton CA, Darcy KM, Maxwell GL, Rocconi RP. Minority participation in phase 1 gynecologic oncology clinical trials: Three decades of inequity. Gynecol Oncol. 2020 06; 157(3):729-732. PMID: 32173047.
      Citations: 8     Fields:    Translation:HumansCTClinical Trials
    12. Rojas C, Tian C, Powell MA, Chan JK, Bateman NW, Conrads TP, Rocconi RP, Jones NL, Shriver CD, Hamilton CA, Maxwell GL, Casablanca Y, Darcy KM. Racial disparities in uterine and ovarian carcinosarcoma: A population-based analysis of treatment and survival. Gynecol Oncol. 2020 04; 157(1):67-77. PMID: 32029291.
      Citations: 8     Fields:    Translation:Humans
    13. Vaz J, Tian C, Richardson MT, Chan JK, Mysona D, Rao UN, Powell MA, Shriver CD, Hamilton CA, Casablanca Y, Maxwell GL, Darcy KM. Impact of adjuvant treatment and prognostic factors in stage I uterine leiomyosarcoma patients treated in Commission on Cancer?-accredited facilities. Gynecol Oncol. 2020 04; 157(1):121-130. PMID: 31954536.
      Citations: 3     Fields:    Translation:Humans
    14. Bateman NW, Teng PN, Hope E, Hood BL, Oliver J, Ao W, Zhou M, Wang G, Tommarello D, Wilson K, Litzy T, Conrads KA, Hamilton CA, Darcy KM, Casablanca Y, Maxwell GL, Bae-Jump V, Conrads TP. Jupiter microtubule-associated homolog 1 (JPT1): A predictive and pharmacodynamic biomarker of metformin response in endometrial cancers. Cancer Med. 2020 02; 9(3):1092-1103. PMID: 31808620; PMCID: PMC6997075.
      Citations: 6     Fields:    Translation:HumansCells
    15. Mai PL, Huang HQ, Wenzel LB, Han PK, Moser RP, Rodriguez GC, Boggess J, Rutherford TJ, Cohn DE, Kauff ND, Phillips KA, Wilkinson K, Wenham RM, Hamilton C, Powell MA, Walker JL, Greene MH, Hensley ML. Prospective follow-up of quality of life for participants undergoing risk-reducing salpingo-oophorectomy or ovarian cancer screening in GOG-0199: An NRG Oncology/GOG study. Gynecol Oncol. 2020 01; 156(1):131-139. PMID: 31759774.
      Citations: 1     Fields:    Translation:Humans
    16. Leath CA, Hamilton CA. Assessing recurrence risk following intraperitoneal chemotherapy for ovarian cancer: A day late and a dollar short? Gynecol Oncol Rep. 2019 Aug; 29:111-112. PMID: 31467963; PMCID: PMC6710552.
      Citations:    
    17. Brown TA, Byrd K, Vreeland TJ, Clifton GT, Jackson DO, Hale DF, Herbert GS, Myers JW, Greene JM, Berry JS, Martin J, Elkas JC, Conrads TP, Darcy KM, Hamilton CA, Maxwel GL, Peoples GE. Final analysis of a phase I/IIa trial of the folate-binding protein-derived E39 peptide vaccine to prevent recurrence in ovarian and endometrial cancer patients. Cancer Med. 2019 08; 8(10):4678-4687. PMID: 31274231; PMCID: PMC6712444.
      Citations: 17     Fields:    Translation:HumansCTClinical Trials
    18. Tarney CM, Wang G, Bateman NW, Conrads KA, Zhou M, Hood BL, Loffredo J, Tian C, Darcy KM, Hamilton CA, Casablanca Y, Lokshin A, Conrads TP, Maxwell GL. Biomarker panel for early detection of endometrial cancer in the Prostate, Lung, Colorectal, and Ovarian cancer screening trial. Am J Obstet Gynecol. 2019 11; 221(5):472.e1-472.e10. PMID: 31279844.
      Citations: 7     Fields:    Translation:Humans
    19. Rose PG, Java JJ, Salani R, Geller MA, Secord AA, Tewari KS, Bender DP, Mutch DG, Friedlander ML, Van Le L, Method MW, Hamilton CA, Lee RB, Wenham RM, Guntupalli SR, Markman M, Muggia FM, Armstrong DK, Bookman MA, Burger RA, Copeland LJ. Nomogram for Predicting Individual Survival After Recurrence of Advanced-Stage, High-Grade Ovarian Carcinoma. Obstet Gynecol. 2019 02; 133(2):245-254. PMID: 30633128; PMCID: PMC6551603.
      Citations: 18     Fields:    Translation:Humans
    20. Dubil EA, Tian C, Wang G, Tarney CM, Bateman NW, Levine DA, Conrads TP, Hamilton CA, Maxwell GL, Darcy KM. Racial disparities in molecular subtypes of endometrial cancer. Gynecol Oncol. 2018 04; 149(1):106-116. PMID: 29605044.
      Citations: 25     Fields:    Translation:Humans
    21. Eskander RN, Kauderer J, Tewari KS, Mannel RS, Bristow RE, O'Malley DM, Rubin SC, Glaser GE, Hamilton CA, Fujiwara K, Huh WK, Ueland F, Stephan JM, Burger RA. Correlation between Surgeon's assessment and radiographic evaluation of residual disease in women with advanced stage ovarian cancer reported to have undergone optimal surgical cytoreduction: An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol. 2018 06; 149(3):525-530. PMID: 29550184.
      Citations: 11     Fields:    Translation:Humans
    22. Tarney CM, Tian C, Craig ER, Crothers BA, Chan JK, Gist GD, Bateman NW, Conrads TP, Hamilton CA, Larry Maxwell G, Darcy KM. Relative Effects of Age, Race, and Stage on Mortality in Gestational Choriocarcinoma. Int J Gynecol Cancer. 2018 02; 28(2):338-345. PMID: 29232272.
      Citations: 4     Fields:    Translation:Humans
    23. Hamilton CA, Miller A, Casablanca Y, Horowitz NS, Rungruang B, Krivak TC, Richard SD, Rodriguez N, Birrer MJ, Backes FJ, Geller MA, Quinn M, Goodheart MJ, Mutch DG, Kavanagh JJ, Maxwell GL, Bookman MA. Clinicopathologic characteristics associated with long-term survival in advanced epithelial ovarian cancer: an NRG Oncology/Gynecologic Oncology Group ancillary data study. Gynecol Oncol. 2018 02; 148(2):275-280. PMID: 29195926; PMCID: PMC5918685.
      Citations: 20     Fields:    Translation:Humans
    24. Waheed S, Dorjbal B, Hamilton CA, Maxwell GL, Rodriguez GC, Syed V. Progesterone and calcitriol reduce invasive potential of endometrial cancer cells by targeting ARF6, NEDD9 and MT1-MMP. Oncotarget. 2017 Dec 26; 8(69):113583-113597. PMID: 29371931; PMCID: PMC5768348.
      Citations: 6     Fields:    
    25. Horowitz NS, Larry Maxwell G, Miller A, Hamilton CA, Rungruang B, Rodriguez N, Richard SD, Krivak TC, Fowler JM, Mutch DG, Van Le L, Lee RB, Argenta P, Bender D, Tewari KS, Gershenson D, Java JJ, Bookman MA. Predictive modeling for determination of microscopic residual disease at primary cytoreduction: An NRG Oncology/Gynecologic Oncology Group 182 Study. Gynecol Oncol. 2018 01; 148(1):49-55. PMID: 29174555; PMCID: PMC5962447.
      Citations: 5     Fields:    Translation:Humans
    26. Bishop EA, Java JJ, Moore KN, Spirtos NM, Pearl ML, Zivanovic O, Kushner DM, Backes F, Hamilton CA, Geller MA, Hurteau J, Mathews C, Wenham RM, Ramirez PT, Zweizig S, Walker JL. Surgical outcomes among elderly women with endometrial cancer treated by laparoscopic hysterectomy: a NRG/Gynecologic Oncology Group study. Am J Obstet Gynecol. 2018 01; 218(1):109.e1-109.e11. PMID: 29037481.
      Citations: 13     Fields:    Translation:Humans
    27. Tarney CM, Tian C, Wang G, Dubil EA, Bateman NW, Chan JK, Elshaikh MA, Cote ML, Schildkraut JM, Shriver CD, Conrads TP, Hamilton CA, Maxwell GL, Darcy KM. Impact of age at diagnosis on racial disparities in endometrial cancer patients. Gynecol Oncol. 2018 04; 149(1):12-21. PMID: 28800945; PMCID: PMC6863162.
      Citations: 14     Fields:    Translation:Humans
    28. Bateman NW, Dubil EA, Wang G, Hood BL, Oliver JM, Litzi TA, Gist GD, Mitchell DA, Blanton B, Phippen NT, Tian C, Zahn CM, Cohn DE, Havrilesky LJ, Berchuck A, Shriver CD, Darcy KM, Hamilton CA, Conrads TP, Maxwell GL. Race-specific molecular alterations correlate with differential outcomes for black and white endometrioid endometrial cancer patients. Cancer. 2017 Oct 15; 123(20):4004-4012. PMID: 28654152.
      Citations: 17     Fields:    Translation:Humans
    29. Teng PN, Bateman NW, Wang G, Litzi T, Blanton BE, Hood BL, Conrads KA, Ao W, Oliver KE, Darcy KM, McGuire WP, Paz K, Sidransky D, Hamilton CA, Maxwell GL, Conrads TP. Establishment and characterization of a platinum- and paclitaxel-resistant high grade serous ovarian carcinoma cell line. Hum Cell. 2017 Jul; 30(3):226-236. PMID: 28251557.
      Citations: 6     Fields:    Translation:HumansAnimalsCells
    30. Jackson DO, Byrd K, Vreeland TJ, Hale DF, Herbert GS, Greene JM, Schneble EJ, Berry JS, Trappey AF, Clifton GT, Hardin MO, Martin J, Elkas JC, Conrads TP, Darcy KM, Hamilton CA, Maxwell GL, Peoples GE. Interim analysis of a phase I/IIa trial assessing E39+GM-CSF, a folate binding protein vaccine, to prevent recurrence in ovarian and endometrial cancer patients. Oncotarget. 2017 Feb 28; 8(9):15912-15923. PMID: 27852036; PMCID: PMC5362533.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    31. Mai PL, Piedmonte M, Han PK, Moser RP, Walker JL, Rodriguez G, Boggess J, Rutherford TJ, Zivanovic O, Cohn DE, Thigpen JT, Wenham RM, Friedlander ML, Hamilton CA, Bakkum-Gamez J, Olawaiye AB, Hensley ML, Greene MH, Huang HQ, Wenzel L. Factors associated with deciding between risk-reducing salpingo-oophorectomy and ovarian cancer screening among high-risk women enrolled in GOG-0199: An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol. 2017 04; 145(1):122-129. PMID: 28190649.
      Citations: 14     Fields:    Translation:Humans
    32. Bokhari AA, Lee LR, Raboteau D, Turbov J, Rodriguez IV, Pike JW, Hamilton CA, Maxwell GL, Rodriguez GC, Syed V. Progesterone potentiates the growth inhibitory effects of calcitriol in endometrial cancer via suppression of CYP24A1. Oncotarget. 2016 Nov 22; 7(47):77576-77590. PMID: 27769055; PMCID: PMC5363606.
      Citations: 6     Fields:    Translation:HumansCells
    33. Rungruang BJ, Miller A, Krivak TC, Horowitz NS, Rodriguez N, Hamilton CA, Backes FJ, Carson LF, Friedlander M, Mutch DG, Goodheart MJ, Tewari KS, Wenham RM, Bookman MA, Maxwell GL, Richard SD. What is the role of retroperitoneal exploration in optimally debulked stage IIIC epithelial ovarian cancer? An NRG Oncology/Gynecologic Oncology Group ancillary data study. Cancer. 2017 May 15; 123(6):985-993. PMID: 27864921; PMCID: PMC5339038.
      Citations: 2     Fields:    Translation:Humans
    34. Phippen NT, Bateman NW, Wang G, Conrads KA, Ao W, Teng PN, Litzi TA, Oliver J, Maxwell GL, Hamilton CA, Darcy KM, Conrads TP. NUAK1 (ARK5) Is Associated with Poor Prognosis in Ovarian Cancer. Front Oncol. 2016; 6:213. PMID: 27833898; PMCID: PMC5081368.
      Citations: 21     
    35. Bokhari AA, Baker TM, Dorjbal B, Waheed S, Zahn CM, Hamilton CA, Maxwell GL, Syed V. Nestin suppression attenuates invasive potential of endometrial cancer cells by downregulating TGF-? signaling pathway. Oncotarget. 2016 Oct 25; 7(43):69733-69748. PMID: 27626172; PMCID: PMC5342511.
      Citations: 12     Fields:    Translation:HumansCells
    36. Fader AN, Java J, Tenney M, Ricci S, Gunderson CC, Temkin SM, Spirtos N, Kushnir CL, Pearl ML, Zivanovic O, Tewari KS, O'Malley D, Hartenbach EM, Hamilton CA, Gould NS, Mannel RS, Rodgers W, Walker JL. Impact of histology and surgical approach on survival among women with early-stage, high-grade uterine cancer: An NRG Oncology/Gynecologic Oncology Group ancillary analysis. Gynecol Oncol. 2016 Dec; 143(3):460-465. PMID: 27743738.
      Citations: 28     Fields:    Translation:HumansCTClinical Trials
    37. Rodriguez GC, Turbov J, Rosales R, Yoo J, Hunn J, Zappia KJ, Lund K, Barry CP, Rodriguez IV, Pike JW, Conrads TP, Darcy KM, Maxwell GL, Hamilton CA, Syed V, Thaete LG. Progestins inhibit calcitriol-induced CYP24A1 and synergistically inhibit ovarian cancer cell viability: An opportunity for chemoprevention. Gynecol Oncol. 2016 10; 143(1):159-167. PMID: 27106018.
      Citations: 14     Fields:    Translation:HumansAnimalsCells
    38. Phippen NT, Havrilesky LJ, Barnett JC, Hamilton CA, Stany MP, Lowery WJ. Does Routine Posttreatment PET/CT Add Value to the Care of Women With Locally Advanced Cervical Cancer? Int J Gynecol Cancer. 2016 06; 26(5):944-50. PMID: 27051057.
      Citations: 2     Fields:    Translation:Humans
    39. Hope ER, Mhawech-Fauceglia P, Pejovic T, Zahn CM, Wang G, Conrads TP, Larry Maxwell G, Hamilton CA, Darcy KM, Syed V. Nestin: A biomarker of aggressive uterine cancers. Gynecol Oncol. 2016 Mar; 140(3):503-11. PMID: 26718725.
      Citations: 3     Fields:    Translation:Humans
    40. Bateman NW, Shoji Y, Conrads KA, Stroop KD, Hamilton CA, Darcy KM, Maxwell GL, Risinger JI, Conrads TP. Identification and functional characterization of a novel bipartite nuclear localization sequence in ARID1A. Biochem Biophys Res Commun. 2016 Jan 01; 469(1):114-119. PMID: 26614907.
      Citations: 3     Fields:    Translation:Cells
    41. Horowitz N, Miller A, Rungruang B, Richard S, Rodriguez N, Bookman MA, Hamilton C, Krivak T, Maxwell GL. Reply to G.D. Aletti et al. J Clin Oncol. 2015 Oct 20; 33(30):3521-2. PMID: 26304879.
      Citations: 1     Fields:    Translation:Humans
    42. Bateman NW, Jaworski E, Ao W, Wang G, Litzi T, Dubil E, Marcus C, Conrads KA, Teng PN, Hood BL, Phippen NT, Vasicek LA, McGuire WP, Paz K, Sidransky D, Hamilton CA, Maxwell GL, Darcy KM, Conrads TP. Elevated AKAP12 in paclitaxel-resistant serous ovarian cancer cells is prognostic and predictive of poor survival in patients. J Proteome Res. 2015 Apr 03; 14(4):1900-10. PMID: 25748058; PMCID: PMC4612617.
      Citations: 25     Fields:    Translation:HumansCells
    43. Hood BL, Liu B, Alkhas A, Shoji Y, Challa R, Wang G, Ferguson S, Oliver J, Mitchell D, Bateman NW, Zahn CM, Hamilton CA, Payson M, Lessey B, Fazleabas AT, Maxwell GL, Conrads TP, Risinger JI. Proteomics of the human endometrial glandular epithelium and stroma from the proliferative and secretory phases of the menstrual cycle. Biol Reprod. 2015 Apr; 92(4):106. PMID: 25695723.
      Citations: 15     Fields:    Translation:HumansAnimalsCells
    44. Horowitz NS, Miller A, Rungruang B, Richard SD, Rodriguez N, Bookman MA, Hamilton CA, Krivak TC, Maxwell GL. Does aggressive surgery improve outcomes? Interaction between preoperative disease burden and complex surgery in patients with advanced-stage ovarian cancer: an analysis of GOG 182. J Clin Oncol. 2015 Mar 10; 33(8):937-43. PMID: 25667285; PMCID: PMC4348639.
      Citations: 81     Fields:    Translation:Humans
    45. Teng PN, Bateman NW, Darcy KM, Hamilton CA, Maxwell GL, Bakkenist CJ, Conrads TP. Pharmacologic inhibition of ATR and ATM offers clinically important distinctions to enhancing platinum or radiation response in ovarian, endometrial, and cervical cancer cells. Gynecol Oncol. 2015 Mar; 136(3):554-61. PMID: 25560806; PMCID: PMC4382918.
      Citations: 44     Fields:    Translation:HumansCells
    46. Lowery WJ, Stany MP, Phippen NT, Bunch KP, Oliver KE, Tian C, Maxwell GL, Darcy KM, Hamilton CA. Survival advantage of marriage in uterine cancer patients contrasts poor outcome for widows: a Surveillance, Epidemiology and End Results study. Gynecol Oncol. 2015 Feb; 136(2):328-35. PMID: 25546111.
      Citations: 6     Fields:    Translation:Humans
    47. McCluskey TC, Stany MP, Hamilton CA. Pyocolpos presenting as a large pelvic mass after total colpocleisis. Am J Obstet Gynecol. 2015 Jan; 212(1):113.e1-2. PMID: 25305401.
      Citations:    Fields:    Translation:Humans
    48. Sherman ME, Piedmonte M, Mai PL, Ioffe OB, Ronnett BM, Van Le L, Ivanov I, Bell MC, Blank SV, DiSilvestro P, Hamilton CA, Tewari KS, Wakeley K, Kauff ND, Yamada SD, Rodriguez G, Skates SJ, Alberts DS, Walker JL, Minasian L, Lu K, Greene MH. Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199. J Clin Oncol. 2014 Oct 10; 32(29):3275-83. PMID: 25199754.
      Citations: 37     Fields:    Translation:HumansCTClinical Trials
    49. Maxwell GL, Shoji Y, Darcy K, Litzi T, Berchuck A, Hamilton CA, Conrads TP, Risinger JI. MicroRNAs in endometrial cancers from black and white patients. Am J Obstet Gynecol. 2015 Feb; 212(2):191.e1-10. PMID: 25174797.
      Citations: 17     Fields:    Translation:HumansCells
    50. Bokhari AA, Lee LR, Raboteau D, Hamilton CA, Maxwell GL, Rodriguez GC, Syed V. Progesterone inhibits endometrial cancer invasiveness by inhibiting the TGF? pathway. Cancer Prev Res (Phila). 2014 Oct; 7(10):1045-55. PMID: 25070663.
      Citations: 20     Fields:    Translation:HumansCells
    51. Marcus CS, Maxwell GL, Darcy KM, Hamilton CA, McGuire WP. Current approaches and challenges in managing and monitoring treatment response in ovarian cancer. J Cancer. 2014 Jan 01; 5(1):25-30. PMID: 24396495; PMCID: PMC3881218.
      Citations: 66     
    52. Zeligs KP, Byrd K, Tarney CM, Howard RS, Sims BD, Hamilton CA, Stany MP. A clinicopathologic study of vaginal intraepithelial neoplasia. Obstet Gynecol. 2013 Dec; 122(6):1223-30. PMID: 24201676.
      Citations: 10     Fields:    Translation:HumansPHPublic Health
    53. Teng PN, Wang G, Hood BL, Conrads KA, Hamilton CA, Maxwell GL, Darcy KM, Conrads TP. Identification of candidate circulating cisplatin-resistant biomarkers from epithelial ovarian carcinoma cell secretomes. Br J Cancer. 2014 Jan 07; 110(1):123-32. PMID: 24178762; PMCID: PMC3887292.
      Citations: 31     Fields:    Translation:HumansCells
    54. Risinger JI, Allard J, Chandran U, Day R, Chandramouli GV, Miller C, Zahn C, Oliver J, Litzi T, Marcus C, Dubil E, Byrd K, Cassablanca Y, Becich M, Berchuck A, Darcy KM, Hamilton CA, Conrads TP, Maxwell GL. Gene expression analysis of early stage endometrial cancers reveals unique transcripts associated with grade and histology but not depth of invasion. Front Oncol. 2013; 3:139. PMID: 23785665; PMCID: PMC3683664.
      Citations: 18     
    55. Rodriguez N, Miller A, Richard SD, Rungruang B, Hamilton CA, Bookman MA, Maxwell GL, Horowitz NS, Krivak TC. Upper abdominal procedures in advanced stage ovarian or primary peritoneal carcinoma patients with minimal or no gross residual disease: an analysis of Gynecologic Oncology Group (GOG) 182. Gynecol Oncol. 2013 Sep; 130(3):487-92. PMID: 23791702.
      Citations: 18     Fields:    Translation:Humans
    56. Zeligs KP, Javitt MC, Barner R, Hamilton CA. Atypical ovarian calcifications associated with bilateral borderline ovarian tumors. J Ultrasound Med. 2013 Jun; 32(6):1059-61. PMID: 23716528.
      Citations: 1     Fields:    Translation:Humans
    57. Lee LR, Teng PN, Nguyen H, Hood BL, Kavandi L, Wang G, Turbov JM, Thaete LG, Hamilton CA, Maxwell GL, Rodriguez GC, Conrads TP, Syed V. Progesterone enhances calcitriol antitumor activity by upregulating vitamin D receptor expression and promoting apoptosis in endometrial cancer cells. Cancer Prev Res (Phila). 2013 Jul; 6(7):731-43. PMID: 23682076.
      Citations: 21     Fields:    Translation:HumansCells
    58. Byrd K, Stany MP, Herbold NC, Leath CA, Hamilton CA. Growing teratoma syndrome: Brief communication and algorithm for management. Aust N Z J Obstet Gynaecol. 2013 Jun; 53(3):318-21. PMID: 23600854.
      Citations: 5     Fields:    Translation:Humans
    59. Maxwell GL, Allard J, Gadisetti CV, Litzi T, Casablanca Y, Chandran U, Darcy KM, Levine DA, Berchuck A, Hamilton CA, Conrads TP, Risinger JI. Transcript expression in endometrial cancers from Black and White patients. Gynecol Oncol. 2013 Jul; 130(1):169-73. PMID: 23603370.
      Citations: 7     Fields:    Translation:Humans
    60. Hope E, Smith M, Zeligs K, Hamilton CA, Miller C. Takotsubo cardiomyopathy following laparoscopic port placement in a patient with ovarian cancer. Gynecol Oncol Case Rep. 2012; 3:16-7. PMID: 24371655; PMCID: PMC3862325.
      Citations: 1     
    61. Chappell NP, Teng PN, Hood BL, Wang G, Darcy KM, Hamilton CA, Maxwell GL, Conrads TP. Mitochondrial proteomic analysis of cisplatin resistance in ovarian cancer. J Proteome Res. 2012 Sep 07; 11(9):4605-14. PMID: 22900918.
      Citations: 27     Fields:    Translation:HumansCells
    62. Cohen JG, Kiet T, Shin JY, Sherman AE, Hamilton CA, Brooks RA, Ueda SM, Chen LM, Kapp DS, Chan JK. Factors associated with publication of plenary presentations at the Society of Gynecologic Oncologists annual meeting. Gynecol Oncol. 2013 Jan; 128(1):128-131. PMID: 22892364.
      Citations: 4     Fields:    
    63. Rungruang B, Miller A, Richard SD, Hamilton CA, Rodriguez N, Bookman MA, Maxwell GL, Krivak TC, Horowitz NS. Should stage IIIC ovarian cancer be further stratified by intraperitoneal vs. retroperitoneal only disease?: a Gynecologic Oncology Group study. Gynecol Oncol. 2012 Jan; 124(1):53-8. PMID: 22032836.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    64. Alkhas A, Hood BL, Oliver K, Teng PN, Oliver J, Mitchell D, Hamilton CA, Maxwell GL, Conrads TP. Standardization of a sample preparation and analytical workflow for proteomics of archival endometrial cancer tissue. J Proteome Res. 2011 Nov 04; 10(11):5264-71. PMID: 21932769.
      Citations: 14     Fields:    Translation:Humans
    65. Hamilton CA, Miller A, Miller C, Krivak TC, Farley JH, Chernofsky MR, Stany MP, Rose GS, Markman M, Ozols RF, Armstrong DK, Maxwell GL. The impact of disease distribution on survival in patients with stage III epithelial ovarian cancer cytoreduced to microscopic residual: a Gynecologic Oncology Group study. Gynecol Oncol. 2011 Sep; 122(3):521-6. PMID: 21683993; PMCID: PMC3670691.
      Citations: 25     Fields:    Translation:Humans
    66. Ramsay LB, Stany MP, Edison JD, Bernstein SA, Schlegal KE, Hamilton CA. Gemcitabine-associated large vessel vasculitis presenting as fever of unknown origin. J Clin Rheumatol. 2010 Jun; 16(4):181-2. PMID: 20407388.
      Citations: 6     Fields:    Translation:Humans
    67. Maxwell GL, Tian C, Risinger JI, Hamilton CA, Barakat RR, Gynecologic Oncology Group Study. Racial disparities in recurrence among patients with early-stage endometrial cancer: is recurrence increased in black patients who receive estrogen replacement therapy? Cancer. 2008 Sep 15; 113(6):1431-7. PMID: 18698590; PMCID: PMC4435958.
      Citations: 15     Fields:    Translation:Humans
    68. Hamilton CA, Maxwell GL, Chernofsky MR, Bernstein SA, Farley JH, Rose GS. Intraperitoneal bevacizumab for the palliation of malignant ascites in refractory ovarian cancer. Gynecol Oncol. 2008 Dec; 111(3):530-2. PMID: 18561992.
      Citations: 29     Fields:    Translation:Humans
    69. Stany MP, Hamilton CA. Benign disorders of the ovary. Obstet Gynecol Clin North Am. 2008 Jun; 35(2):271-84, ix. PMID: 18486841.
      Citations: 8     Fields:    Translation:Humans
    70. Hamilton CA, Kapp DS, Chan JK. Clinical aspects of uterine papillary serous carcinoma. Curr Opin Obstet Gynecol. 2008 Feb; 20(1):26-33. PMID: 18197002.
      Citations: 9     Fields:    Translation:Humans
    71. Chan JK, Hamilton CA, Anderson EM, Cheung MK, Baker J, Husain A, Teng NN, Kong CS, Negrin RS. A novel technique for the enrichment of primary ovarian cancer cells. Am J Obstet Gynecol. 2007 Nov; 197(5):507.e1-5. PMID: 17980191.
      Citations: 8     Fields:    Translation:HumansCells
    72. Hamilton CA, Kao JM, Coutre SE, Teng NN. Acute postoperative thrombotic thrombocytopenic purpura following hysterectomy and lymphadenectomy for endometrial cancer. Gynecol Oncol. 2007 Aug; 106(2):423-6. PMID: 17499845.
      Citations: 3     Fields:    Translation:Humans
    73. Hamilton CA, Berek JS. Intraperitoneal chemotherapy for ovarian cancer. Curr Opin Oncol. 2006 Sep; 18(5):507-15. PMID: 16894301.
      Citations: 3     Fields:    Translation:Humans
    74. Hamilton CA, Cheung MK, Osann K, Balzer B, Berman ML, Husain A, Teng NN, Kapp DS, Chan JK. The effect of adjuvant chemotherapy versus whole abdominopelvic radiation on the survival of patients with advanced stage uterine papillary serous carcinoma. Gynecol Oncol. 2006 Nov; 103(2):679-83. PMID: 16793126.
      Citations: 5     Fields:    Translation:Humans
    75. Liou WS, Hamilton CA, Cheung MK, Osann K, Longacre TA, Teng NN, Husain A, Dirbas FM, Chan JK. Outcomes of women with metachronous breast and ovarian carcinomas. Gynecol Oncol. 2006 Oct; 103(1):190-4. PMID: 16569424.
      Citations: 4     Fields:    Translation:Humans
    76. Chan JK, Hamilton CA, Cheung MK, Karimi M, Baker J, Gall JM, Schulz S, Thorne SH, Teng NN, Contag CH, Lum LG, Negrin RS. Enhanced killing of primary ovarian cancer by retargeting autologous cytokine-induced killer cells with bispecific antibodies: a preclinical study. Clin Cancer Res. 2006 Mar 15; 12(6):1859-67. PMID: 16551871.
      Citations: 56     Fields:    Translation:HumansAnimalsCells
    77. Hamilton CA, Cheung MK, Osann K, Chen L, Teng NN, Longacre TA, Powell MA, Hendrickson MR, Kapp DS, Chan JK. Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers. Br J Cancer. 2006 Mar 13; 94(5):642-6. PMID: 16495918; PMCID: PMC2361201.
      Citations: 200     Fields:    Translation:Humans
    78. Hamilton CA, Liou WS, Osann K, Berman ML, Husain A, Teng NN, Kapp DS, Chan JK. Impact of adjuvant therapy on survival of patients with early-stage uterine papillary serous carcinoma. Int J Radiat Oncol Biol Phys. 2005 Nov 01; 63(3):839-44. PMID: 16199314.
      Citations: 6     Fields:    Translation:Humans
    79. Robinson WR, Hamilton CA, Michaels SH, Kissinger P. Effect of excisional therapy and highly active antiretroviral therapy on cervical intraepithelial neoplasia in women infected with human immunodeficiency virus. Am J Obstet Gynecol. 2001 Mar; 184(4):538-43. PMID: 11262450.
      Citations: 6     Fields:    Translation:Humans
    80. Hamilton CA, Link KM, Salido TB, Epstein FH, Hundley WG. Is imaging at intermediate doses necessary during dobutamine stress magnetic resonance imaging? J Cardiovasc Magn Reson. 2001; 3(4):297-302. PMID: 11777220.
      Citations: 12     Fields:    Translation:Humans
    81. Hamilton CA, Robinson WR. Femoral artery occlusion following pelvic cancer surgery. Gynecol Oncol. 1996 Oct; 63(1):151-3. PMID: 8898187.
      Citations: 2     Fields:    Translation:Humans
    Hamilton's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (362)
    Explore
    _
    Co-Authors (2)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _